Journal of Health Policy & Outcomes Research

PRO MEDICINA Foundation

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Journal of Health Policy & Outcomes Research is an open-access journal published by PRO MEDICINA Foundation in Poland, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 5 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
PRO MEDICINA Foundation
ISSN
2543-604X · 2299-1247
Country
Poland
Languages
english
Access
Open access
Articles in DOAJ
0
Declared review time
5 weeks
Declared peer-review model
double_blind
Official website
https://www.jhpor.com/

Index listings

  • DOAJ · 2021-05-10
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
5 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

0

Average review time (journal-declared via DOAJ)

5weeks

Works in OpenAlex

229

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

6

i10-index

4

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2021-05-10
Added to DOAJ
2021-05-10
Declared plagiarism screening
Not declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
100%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Medicine (General)

LCC codes

R5-920

Subject areas

  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Economics and Policy
  • Global Health Care Issues
  • Global Health Care Issues
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
Show all subjects (50)
  • Economic and Financial Impacts of Cancer
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Economic and Financial Impacts of Cancer
  • Immunodeficiency and Autoimmune Disorders
  • Biosimilars and Bioanalytical Methods
  • Immunodeficiency and Autoimmune Disorders
  • Biosimilars and Bioanalytical Methods
  • Monoclonal and Polyclonal Antibodies Research
  • Pharmaceutical industry and healthcare
  • Pharmaceutical industry and healthcare
  • Healthcare Systems and Reforms
  • Healthcare Systems and Reforms
  • Monoclonal and Polyclonal Antibodies Research
  • Vaccine Coverage and Hesitancy
  • Healthcare Policy and Management
  • Platelet Disorders and Treatments
  • Urticaria and Related Conditions
  • Polish Law and Legal System
  • Polish Legal and Social Issues
  • Healthcare cost, quality, practices
  • Healthcare Policy and Management
  • Urticaria and Related Conditions
  • Platelet Disorders and Treatments
  • Polish Legal and Social Issues
  • Vaccine Coverage and Hesitancy
  • Polish Law and Legal System
  • Healthcare cost, quality, practices
  • Retinal Diseases and Treatments
  • COVID-19 Pandemic Impacts
  • Asthma and respiratory diseases
  • Social Issues in Poland
  • Management and Organizational Practices
  • Social Issues in Poland
  • Retinal Diseases and Treatments
  • Asthma and respiratory diseases
  • Management and Organizational Practices
  • COVID-19 Pandemic Impacts
  • Schizophrenia research and treatment
  • Blood Pressure and Hypertension Studies
  • Schizophrenia research and treatment
  • Blood Pressure and Hypertension Studies

Keywords (DOAJ)

  • pharmacoeconomics
  • public health
  • health outcomes
  • health economics
  • medicine

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: